Uncertainty-Aware Bayesian Deconvolution Enhances Cell-Type Analysis
Publication Title: UBD: incorporating uncertainty in cell type proportion estimates from bulk samples to infer cell-type-specific profiles
Summary
- Question
- This study introduced a novel statistical method called Uncertainty-aware Bayesian Deconvolution (UBD) to address the limitations of current approaches in estimating cell-type-specific (CTS) profiles from bulk tissue data. The researchers aimed to improve the accuracy of CTS data by incorporating uncertainty in cell type proportion estimates, which are often treated as fixed in existing methods.
- Why it Matters
- Accurate CTS profiles are crucial for understanding how specific cell types contribute to complex diseases such as Alzheimer’s disease. Traditional methods often overlook the uncertainty in estimating cell type proportions, potentially introducing errors. By explicitly modeling this uncertainty, UBD can improve the reliability of CTS data, enabling more precise identification of disease-related signals. This advancement holds significant implications for medical research, public health, and the development of targeted therapies.
- Methods
- The researchers developed UBD by extending an existing Bayesian framework. UBD integrates data from bulk tissue samples and a reference matrix that characterizes different cell types. The method incorporates uncertainty into cell type proportion estimates using a Dirichlet distribution, a statistical model that captures variability. Simulations and applications to real datasets, including Alzheimer’s disease and autoimmune conditions, were conducted to evaluate UBD’s performance against existing methods.
- Key Findings
- UBD outperformed traditional methods in accurately estimating CTS profiles. Simulations demonstrated that UBD provided more precise correlations between estimated and true CTS data compared to methods that ignored uncertainty. When applied to real datasets, UBD identified more CTS signals, such as differentially expressed genes in Alzheimer’s disease and cell-type-specific genetic variants (eQTLs) in autoimmune conditions. The method was particularly effective for abundant cell types, while its performance for rare cell types showed limited improvement.
- Implications
- UBD offers a robust tool for researchers aiming to extract cell-type-specific insights from bulk tissue data. By improving the accuracy of CTS profiles, the method enhances the ability to identify disease-related genetic and molecular signals. This could lead to more effective diagnostic tools, personalized treatments, and a deeper understanding of cell-type-specific mechanisms in health and disease.
- Next Steps
- Future research should focus on optimizing UBD for rare cell types and further enhancing its computational efficiency. The authors also suggested integrating additional data sources, such as single-cell data, to improve the method’s performance. Exploring applications to other types of biological data, such as DNA methylation, could broaden its utility.
- Funding Information
- This research was supported by the National Institutes of Health (awards U24 HG012108, U01 HG013840, R01DA061926, and R01DA047820). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Yale University also provided funding and support for this research.
Full Citation
Cheng Y, Lin C, Li H, Xu K, Zhao H. UBD: incorporating uncertainty in cell type proportion estimates from bulk samples to infer cell-type-specific profiles. Briefings In Bioinformatics 2026, 27: bbaf711. PMID: 41520227, PMCID: PMC12895075, DOI: 10.1093/bib/bbaf711.
This AI-assisted summary has been reviewed and approved by at least one of the study's authors to ensure it accurately reflects the research.
Authors
Youshu Cheng
First AuthorHongyu Zhao, PhD
Last AuthorIra V. Hiscock Professor of Biostatistics, Professor of Genetics and Professor of Statistics and Data Science